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Background: Smoking is known to be associated with oxidative stress; however, it has not been elucidated
whether the oxidative response is influenced by the intensity of smoking exposure.
Objectives: Evaluate the effect of smoking exposure on the secretion of hydrogen peroxide (H2O2) by the
peripheral blood monocytes of smokers.
Methods: A total of 25 smokers (50.3±8.8 years, 48% male) underwent the following evaluations: spirometry, pulse
oximetry, body composition and total peripheral blood count. Peripheral blood monocyte (PBM) cultures were
isolated and maintained, and IL-6 and TNF-α were measured in the plasma and in the supernatants of spontaneous
and stimulated cultures. H2O2 was evaluated in the supernatants of the PBM cultures, and a subset of the PBM
culture supernatants was stimulated with phorbol myristate acetate (PMA). We also evaluated 38 healthy controls
(49.1±8.2 years, 42% male).
Results: The spontaneous and stimulated monocytes’ secretion of H2O2 were statistically higher in the smokers
than in the healthy controls (p<0.001). The H2O2 secretions were statistically significant higher after stimulation with
PMA in both groups (p<0.001). In the multiple regression analysis, we identified a positive, statistically significant
association between pack-years of smoking and the spontaneous secretion of H2O2 by PBM culture, adjusted for
potential confounding variables. The association between PBM culture secretion of H2O2 and the production of
TNF-α and IL-6 was not significant.
Conclusion: We identified a positive association between higher production of H2O2 in smokers and higher
smoking exposure during life. The influence of pack-years smoking may be a key modifiable factor in oxidative
stress associated to smoking.
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Smoking is a major agent of environmental pollution and is
the leading preventable cause of death worldwide [1].
According to data from the World Health Organization,
smoking is responsible for 85% of deaths due to chronic ob-
structive pulmonary disease (COPD), 30% of cancer deaths
and 25% of deaths from coronary disease [1]. The develop-
ment of smoking-related diseases is associated with the* Correspondence: suzanapneumo@gmail.com
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reproduction in any medium, provided the ordeleterious effects of cigarette smoke, including increased
oxidative stress and inflammatory processes [2,3].
Oxidative stress is associated with higher concentra-
tions of reactive oxygen specimens, including hydrogen
peroxide (H2O2), and this phenomenon is a characteris-
tic response of inflammatory cells to smoking [4-7].
Oxidative stress can further stimulate the inflammatory
process in the airways, increasing the levels of cytokines
and the accumulation of polymorphonuclear leukocytes
(PMNs) [2,8-10]. Moreover, this stress may induce the
oxidation of lipids, lipoproteins, DNA and other proteins
and molecules in ways that impair normal cellular func-
tion and enable the development of many diseases, suchtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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higher concentrations of H2O2 in exhaled breath con-
densate compared with healthy controls [11], which
might be associated with smoking exposure. Oxidative
stress activates proteins that are associated with the de-
struction of parenchymal tissue [11].
An association between active smoking and elevated
oxidative stress in alveolar macrophages is well described
in the literature [2,12,13]; however, whether the intensity
of smoking exposure has an impact on oxidative stress
has been less thoroughly investigated. In the study of
van Beurden et al. [14], the production of superoxide
by PMNs was not associated with the intensity of smok-
ing exposure evaluated by smoking history duration.
Similarly, Yeh et al. [15] did not find an association with
smoking history duration when protein carbonylation
was used as a biomarker for oxidative stress. Therefore,
the aim of this study was to assess the relationship be-
tween systemic oxidative stress, represented by the se-
cretion of H2O2 by peripheral monocytes, and pack-
years of smoking.Methods
We evaluated 25 active smokers (52% female) of at least
10 pack-years and 38 healthy controls self-identified as
never smokers (57.9% female). All of the participants
underwent routine clinical assessments, including spir-
ometry and chest X-ray. The height and weight were
measured, and the body mass index (BMI) was calcu-
lated (kg/m2). The exclusion criteria included pharmaco-
logical treatments in the last three months before
enrollment in the study, a forced expiratory volume in
the first second (FEV1)/Forced vital capacity (FVC) ratio
< 0.70 or significant reversibility (increase >200 mL or
>11% in the value of FEV1 expressed as percentage of
the predicted value) 20 minutes after the inhalation of a
β2-agonist (400 mcg fenoterol) in the spirometry test,
diagnosis of any chronic disease, and inability to under-
stand the study protocol.
The Research Ethics Committee of the Botucatu
Medical School approved the study design, and all of the
participants gave written informed consent.Spirometry test and pulse oximetry
The FEV1 and FVC were obtained from the flow-volume
curve using a spirometer (Ferraris KOKO, Louisville,
CO, USA) before and 20 minutes after the inhalation of
a β2-agonist (400 mcg fenoterol) according to Brazilian
guidelines [16]. The highest value of at least three mea-
surements was selected and expressed as a percentage of
reference values [16]. The pulse oximetry (SpO2%) was
assessed by a portable oximeter (Nonin Medical,
Plymouth, MN, USA).Peripheral blood monocyte isolation and culture (PBM)
PBM cultures were isolated from heparinized blood
drawn between 07:00 – 08:00 using a density gradient
followed by plastic adherence, as described elsewhere
[17]. In brief, the PBM cultures were isolated from
heparinized blood using Histopaque 1077 (Sigma Chem-
ical Co., St Louis, MO, USA) and washed three times
with Hanks’ solution (Sigma Chemical Co.). A cell sus-
pension was prepared with PBMCs at 2×106 cells·mL-1
in Roswell Park Memorial Institute (RPMI)-1640
medium (Sigma Chemical Co.) supplemented with 5%
heat-inactivated autologous serum, 2 mM glutamine,
100 U·mL-1 penicillin and 10 mM HEPES (N-2-hydro-
xyethylpiperazine-N-2-ethanesulfonic acid) buffer (that
hereafter will be referred to as mRPMI) and incubated
for 2 hours in a humidified atmosphere with 5% CO2 at
37°C. Nonadherent cells were removed by three washes
with plain RPMI and counted. The adherent cells were
provided with fresh mRPMI at a volume of 1 mL·1×106
cells-1 and incubated for 24 hours. The supernatants
were collected, centrifuged and stored at −80°C until
cytokine analysis. After the supernatants were harvested,
the adherent cells were stained with nonspecific esterase
staining (Sigma Chemical Co.), and the cell viability was
determined using a trypan blue exclusion test. The
adherent cells contained > 95% monocytes; >98%
were viable.
Interleukin (IL)-6 and tumor necrosis factor alpha (TNF-α)
measurements
Fasting peripheral blood was collected in the early
morning (07.00-08.00 hours), and the plasma was stored
at −80°C until analysis. TNF-α and IL-6 in the spontan-
eous PBM culture supernatant and plasma were assessed
in duplicate by highly sensitive commercial kits using
the enzyme-linked immunosorbent (ELISA) technique
according to the manufacturer’s instructions (BioSource
International Inc, CA, USA). The lower detection limits
were 0.5 pg/mL for TNF-α and 0.16 pg/mL for IL-6.
H2O2 production
The production of H2O2 was determined according to
the method described by Pick & Keisari [18], adapted by
Pick & Mizel [19] and also previous published [3]. After
an 18-hour incubation period, supernatants of cultures
of monocytes were discarded, and the cells were resus-
pended to the original volume in phenol red solution
containing 140 mM of NaCl; 10 mM of phosphate-
buffered saline (pH 7); 5.5 mM of dextrose; 0.56 mM
phenol red; and 0.01 mg/ml of horseradish peroxidase,
type II (Sigma Chemical Co, USA). The supernatants
were divided into two parts, incubated with or without
1 μg of phorbol myristate acetate (PMA) and used as
positive controls for H2O2. After 1 hour, the reaction
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The samples were assayed in quadruplicate. The absorb-
ance was determined using an ELISA reader at 620 nm
against a blank containing phenol red and 1 N NaOH.
The results were expressed as nanomoles of H2O2/
2×105 cells using the standard curve established in each
assay and made up of known molar concentrations of
H2O2 in phenol red buffer solution. In these experimen-
tal conditions, the curve was generated based on the fol-
lowing concentrations: 0.5; 1.0; 1.5 and 2.0 nM of H2O2.
Statistical analysis
The results are presented as the means ± SD for nor-
mally distributed variables and the median (range) when
not normally distributed. The independent t test or
Mann–Whitney was used to compare groups according
to smoking status. The Chi-square test was used to com-
pare proportions between groups. To explore the associ-
ation of H2O2 with markers of systemic inflammation
(TNF-α, IL-6 and neutrophils) and with pack-years of
smoking, we performed multiple regression analysis with
robust standard errors with and without adjustment for
potential confounding variables. A p value of less than
0.05 denotes statistically significant difference (“STATA”
10.0 - Corp, College Station, TX, USA).
Results
The demographic characteristics and the data related to
the spirometry, pulse oximetry and BMI of the smokers
and controls are shown in Table 1. The smokers exhib-
ited lower values of FEV1 (L), FEV1/FVC (%) and BMI
(kg/m2) compared with the healthy controls.
We identified systemic inflammation with higher num-
bers of neutrophils (p=0.004) and higher serum levels of
TNF-α (p<0.001) in active smokers when compared withTable 1 Demographic characteristics
Smokers Controls p
valueN=25 N=38
Age (years) 50.3±8.8 49.1± 8.2 0.57
Gender (M/F) 12/13 16/22 0.84
FEV1 (L) 2.8±0.8 3.3±0.7 0.02
FEV1 (%) 103.2±18.1 112.4±13.5 0.06
FVC (L) 3.7±0.9 3.9±0.9 0.31
FVC (%) 110.9±17.2 111.0±13.9 0.20
FEV1/FVC (%) 77.3±5.7 83.3±4.1 <0.001
Pack-years 27.1±14.6 0.0±0.0 <0.001
SpO2 (%) 96.6±1.4 96.7±1.4 0.79
BMI (Kg/m2) 23.9±4.1 26.4±3.5 0.01
M/F: male/female, FEV1: forced expiratory volume in the first second, FVC:
forced vital capacity, SpO2: pulse oximetry, BMI: body mass index. The values
are presented as the means and standard deviations. The statistical analysis
was performed by t test or Chi-square.never-smoker healthy controls (Table 2). We did not
find differences in the secretion of TNF-α and IL-6 be-
tween the spontaneous PBM cultures of different
groups.
The spontaneous and stimulated PBM culture secre-
tions of H2O2 were statistically higher in the smokers
than in the healthy controls (p<0.001) (Figure 1). The
H2O2 secretion increased significantly after stimulation
with PMA in both groups (p<0.001).
When the smokers and the controls were analyzed in
the multiple regression analysis adjusted for age, gender,
FEV1 (L) and BMI, there was a significant positive asso-
ciation between pack-years of smoking and the spontan-
eous secretion of H2O2 by PBM culture (Table 3).
However, the stimulated PBM culture secretion of H2O2
was not associated with smoking pack-years after adjust-
ments for potential confounding variable. Pack-years of
smoking also exhibited a positive correlation with the
number of leukocytes in the peripheral blood (coeffi-
cient=5.22, p<0.001) and the serum levels of TNF-α
(coefficient=5.41, p=0.007).
We did not find associations between H2O2 secretion
with systemic inflammation evaluated by serum values
and PBM culture secretion of TNF-α or IL-6 or the
number of neutrophils in the peripheral blood (Table 3).
Discussion
This study aimed to evaluate the relationship between
systemic oxidative stress and intensity of smoking expos-
ure. The main finding was that the smokers exhibited
significantly higher secretion of H2O2 than the healthy
controls and that there was a significantly positive asso-
ciation of oxidative stress with pack-years of smoking.
These results confirm that smoking itself is an important
determinant of oxidative stress and that a higher con-
sumption of cigarettes is associated with higher levels of
oxidative stress [12,14,20]. We also reinforce previous
findings that smokers exhibit evidence of systemic in-
flammation compared with healthy controls [7,21].
The relationship between intensity of smoking expos-
ure, through the evaluation of smoking pack-years, and
oxidative stress has previously been investigated in the
literature. However, our study is the first to show a sig-
nificant association between pack-years of smoking and
the secretion of H2O2 by PBMs. Thomassen et al. [22]
did not find a correlation between the number of pack-
years of smoking and the secretion of H2O2 by alveolar
macrophages when assessing smokers and non-smokers.
Similarly, Puri et al. [23] found no correlation between
exhaled ethane air levels and cumulative smoking status.
It is difficult to compare our results with those of these
studies. The study by Thomassen et al. [22] used differ-
ent cultures of cells to evaluate the secretion of H2O2.
Those authors assessed alveolar macrophages, whereas
Table 2 Peripheral blood cells, serum values and spontaneous monocyte secretion of TNF-α and IL-6
Smokers Controls p
N=25 N=38
Leukocytes (cel/mm3) 7249.2±2071.7 6110.5±1111.8 0.09
Neutrophils (cel/mm3) 4406.7±1802.7 3392.2±796.6 0.004
Lymphocytes (cel/mm3) 1879.6±480.5 1885.8±512.9 0.96
TNF-α serum (pg/ml) 5.2 (4.3-5.8) 3.6 (3.4-3.9) <0.001
TNF-α monocytes(pg/ml)* 34.6 (16.1-55.7) 57.4 (22.2-100.9) 0.09
IL-6 serum (pg/ml) 0.40 (0.20-0.80) 0.30 (0.2-0.4) 0.45
IL-6 monocytes (pg/ml) * 1392.6 (272.6-2277.7) 1006.3 (281.9-3048.9) 0.93
TNF-α: tumor necrosis factor alpha, IL-6: interleukin 6, TNF-α and IL-6 monocytes*: measurements of the supernatant of spontaneous peripheral monocyte cultures.
The values are presented as the means and standard deviations or as medians and quartiles. The statistical analysis was performed by t test or Mann–Whitney.
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different outcome to quantify oxidative stress. However,
the sample size of these studies was smaller than that in
our study.
In this study, we demonstrated the higher secretion of
H2O2 in smokers by PBM cultures, either spontaneously
or after stimulation. Nowak et al. [2] demonstrated
increased content of H2O2 in the expired breath conden-
sate of cigarette smokers compared with controls. Our
results are also in agreement with those of Ishida et al.
[24], who identified higher H2O2 production in alveolar
macrophage cultures of rats exposed to cigarette smoke.
In contrast to our results, van Beurden et al. [14] did
not detect differences in the release of superoxide dis-
mutase by PBM cultures, either spontaneously or after
stimulation with PMA, between COPD current/ex-
smoker patients and healthy controls, and the smoking
history did not influence the results when compared by
covariance analysis between groups. The authorsFigure 1 The secretion of hydrogen peroxide, spontaneous and
stimulated with phorbol myristate acetate, in smokers and
healthy controls. Medians (lines), interquartiles (boxes) and ranges
(error bars) are shown. * p<0.001 when comparing controls and
smokers.concluded that superoxide dismutase is only one of the
oxidants that are produced by PBM culture; these cells
also produce H2O2 and hydroxyl radicals. Therefore, the
fact that the secretion of H2O2 by PBM culture is higher
in smokers may indicate an imbalance in which the pro-
duction of reactive oxygen species exceeds the capacity
of the antioxidant defense systems in the systemic
microenvironment. The oxidative stress may already be
occurring to produce oxygen free radicals [25].
Our results showed higher secretion in H2O2 after
stimulation with PMA in both groups, and the smokers
exhibited higher production than the controls. This re-
sult indicates that the smokers included in our study still
have monocytes with efficient immune capacity [26]. We
can speculate that monocyte phagocytosis in smokers is
still functional, although we did not evaluate the im-
mune capacity in our study. In contrast, Correa et al.
showed lower fungicidal activity and secretion of H2O2
by the monocytes of patients with peripheral athero-
sclerosis obliterans compared with those of control
subjects.
Cigarette smoke induces the enhanced recruitment of
mononuclear phagocytes and polymorphonuclear cells
into the lower airways [2,12], and these cells modify oxy-
gen metabolism and release additional H2O2 and other
reactive oxygen species [25]. In our results, we identified
a statistically higher number of neutrophil cells in the
peripheral blood of smokers in comparison with that of
healthy controls and a positive association between the
numbers of leukocytes cells and pack-years of smoking.
These observations are in accordance with a previous
study that demonstrated an accelerated release of poly-
morphonuclear leukocytes from the bone marrow after
smoking exposure [6].
The systemic inflammation induced by smoking
includes neutrophilia and cytokines [6,27,28]. In our
study, we found higher levels of TNF-α in smokers com-
pared with healthy controls. Similarly, Tanni et al. [28]
and Pretescu et al. [9] showed higher TNF-α levels in
smokers compared with healthy non-smokers. We did
Table 3 Multiple regression models for spontaneous and stimulated monocyte production of H2O2
Model Coefficient Coefficient
95% confidence interval 95% confidence interval
Spontaneous production H2O2 Stimulated production H2O2
Pack-years 0.03(0.01; 0.05) 0.04(−0.03; 0.10)
Pack-years 0.03(0.001; 0.05) 0.06(−0.02; 0.14)
TNF-α serum (pg/ml) −0.19(−0.85; 0.48) −0.48(−1.35; 0.39)
Pack-years 0.02(0.001; 0.04) 0.04(−0.03; 0.11)
TNF-α monocytes (pg/ml) −0.0007(−0.002; 0.0007) −0.001(−0.009; 0.004)
Pack-years 0.02(0.005; 0.06) 0.03(−0.03; 0.10)
IL-6 serum (pg/ml) 0.19(−0.40; 0.77) 0.61(−1.21; 2.43)
Pack-years 0.0(0.005; 0.05) 0.06(−0.006; 0.13)
IL-6 monocytes (pg/ml) −1.5e-04(−3.7e-04; 6.5e-06) −2.5e-04(−9.1e-04; 4.0e-04)
Pack-years 0.02(−0.004; 0.04) 0.01(−0.06; 0.09)
Neutrophils (cel/mm3) 0.0001(−0.00002; 0.0003) 0.0005(−0.0002; 0.001)
H2O2: peroxide hydrogen; TNF- α: tumor necrosis factor alpha; IL-6: interleukin 6. Monocyte production of H2O2 was stimulated by phorbol myristate acetate.
All of the multiple regression models with robust standard errors were adjusted for potential confounding variables (age, gender, forced expiratory volume in the
first second and body mass index).
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PBM culture in both groups, and the literature reveals
controversial results that are dependent on the cell cul-
ture methods [7,21]. In agreement with our results,
Ryder et al. [21] utilized cell cultures without stimulus
and did not find increased values of TNF-α production
by PBM cultures in smokers compared with controls. In
contrast, Zeidel et al. [7] identified increased production
of the pro-inflammatory cytokines (IL-1β, IL-6 and
TNF-α) in smokers compared with non-smoking sub-
jects, however, these authors analyzed cell cultures sti-
mulated with lipopolysaccharide.
The limitations of our study need to be addressed.
First, this study is cross sectional, and we are not
explaining the cause-and-effect relationships among
events. Second, we did not evaluate whether different
smoking pack-years or cigarettes-day can induce greater
secretion of H2O2 to confirm our results. Third, we did
not assess the other biomarkers of oxidative stress and
antioxidants to better understand the biological response
to smoking pack-years.
In conclusion, we identified an association between
higher secretions of H2O2 and smokers compared with
healthy controls. The influence of pack-years smoking
may be a key modifiable factor in oxidative stress asso-
ciated to smoking.
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